Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Vaccines for the elderly
L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J. R. Masclans, M. Pérez, J. Almirall, L. Lorente, A. Marqués, L
L. S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli, G. L
L. Boyanova  Clinical Microbiology and Infection 
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome  J. Guinea, M. Torres-Narbona, P.
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
P. Melin  Clinical Microbiology and Infection 
G. Cornaglia, A. Lönnroth, M. Struelens 
Gut bacterial microbiota and obesity
L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Migrant health—a cause for concern?
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis  G. Choudhury,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Candida glabrata fungaemia in intensive care units
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
The microarray technology: facts and controversies
Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit  A. Tsakris, A. Ikonomidis,
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents  S. Brown, S.G.B. Amyes  Clinical.
Louis Pasteur, from crystals of life to vaccination
Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans?  J.-Y. Madec, M. Haenni, P. Nordmann,
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
Surveillance of Legionnaires’ disease in Austria
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
B. Gordts  Clinical Microbiology and Infection 
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit  E. Theocharidou, B. Agarwal, G. Jeffrey,
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals  H. von.
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Update on antifungal resistance in Aspergillus and Candida
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Antimicrobial drug development – the past, the present, and the future
Vaccines for the elderly
S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K
An after-hours clinical liaison blood culture service—is it worth it?
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Are we losing the fight against malaria one more time?
B.A. Cunha  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology and Infection  Volume 20, Issue 9, Pages 854-861 (September 2014) DOI: 10.1111/1469-0691.12748 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 A schematic of risk factors associated with carbapenem-resistant Enterobacteriaceae colonization, infection, or both. Those in italics are potentially preventable with appropriate infection control or antimicrobial stewardship. COPD, chronic obstructive pulmonary disease; ICU, intensive-care unit. Clinical Microbiology and Infection 2014 20, 854-861DOI: (10.1111/1469-0691.12748) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.